Filing Details
- Accession Number:
- 0001110803-11-000113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-27 20:34:56
- Reporting Period:
- 2011-06-23
- Filing Date:
- 2011-06-27
- Accepted Time:
- 2011-06-27 20:34:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189130 | T Jay Flatley | 9885 Towne Centre Drive San Diego CA 92121-1975 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-06-23 | 25,000 | $4.30 | 367,853 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-06-23 | 17,553 | $73.46 | 350,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-06-23 | 7,447 | $74.08 | 342,853 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-06-23 | 25,000 | $0.00 | 25,000 | $4.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,000 | 2005-03-25 | 2015-02-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 15,000 | Indirect | by Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 17,553 shares sold ranging from $72.925 to $73.92 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 7,447 shares sold ranging from $73.93 to $74.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.